EVEROLIMUS vs OFEV

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 16, 2026·How we rate

Possible drug interaction. EVEROLIMUS and OFEV are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EVEROLIMUS	OFEV
Rating	70/100	72/100
Pharmacy pays	~$229.16 /30	—
Type	RX	RX
Active ingredient	EVEROLIMUS	NINTEDANIB ESYLATE
Manufacturer	Biocon Pharma	Boehringer Ingelheim
Dosage forms	Tablet	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	None
Half-life	about 30 hours (mean terminal elimination half-life)	—
Treats	—	Idiopathic Pulmonary Fibrosis

everolimus ofev

Rating

70/100

72/100

Pharmacy pays

~$229.16 /30

—

Type

Active ingredient

EVEROLIMUS

NINTEDANIB ESYLATE

Manufacturer

Biocon Pharma

Boehringer Ingelheim

Dosage forms

Tablet

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Half-life

about 30 hours (mean terminal elimination half-life)

—

Treats

—

Idiopathic Pulmonary Fibrosis

Frequently asked questions

Which is better-rated, Everolimus or Ofev?

By our independent rating, Ofev scores higher — 3.6 vs 3.5 out of 5 for Everolimus. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Everolimus and Ofev?

Everolimus contains Everolimus, while Ofev contains Nintedanib Esylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.